Anne Samuel
Stock Analyst at JP Morgan
(1.83)
# 3,174
Out of 5,182 analysts
67
Total ratings
50%
Success rate
-2.91%
Average return
Main Sectors:
Stocks Rated by Anne Samuel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVH Evolent Health | Maintains: Overweight | $13 → $7 | $2.84 | +146.48% | 13 | Nov 17, 2025 | |
| HQY HealthEquity | Maintains: Overweight | $125 → $126 | $86.04 | +46.44% | 9 | Sep 3, 2025 | |
| VEEV Veeva Systems | Maintains: Neutral | $274 → $290 | $167.95 | +72.67% | 7 | Aug 28, 2025 | |
| PGNY Progyny | Maintains: Neutral | $23 → $25 | $18.12 | +37.97% | 8 | Aug 26, 2025 | |
| DOCS Doximity | Maintains: Neutral | $63 → $60 | $24.71 | +142.82% | 7 | May 27, 2025 | |
| IQV IQVIA Holdings | Maintains: Overweight | $232 → $177 | $176.46 | +0.31% | 7 | May 19, 2025 | |
| OMCL Omnicell | Maintains: Neutral | $44 → $36 | $38.28 | -5.96% | 5 | Mar 20, 2025 | |
| PHR Phreesia | Maintains: Overweight | $27 → $28 | $9.17 | +205.34% | 2 | Sep 9, 2024 | |
| CCSI Consensus Cloud Solutions | Downgrades: Underweight | $19 → $21 | $27.57 | -23.83% | 3 | Sep 9, 2024 | |
| HCAT Health Catalyst | Maintains: Overweight | $10 → $13 | $1.32 | +884.85% | 3 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $24 → $27 | $25.80 | +4.65% | 2 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $7 → $5 | $1.03 | +385.44% | 1 | Jul 31, 2024 |
Evolent Health
Nov 17, 2025
Maintains: Overweight
Price Target: $13 → $7
Current: $2.84
Upside: +146.48%
HealthEquity
Sep 3, 2025
Maintains: Overweight
Price Target: $125 → $126
Current: $86.04
Upside: +46.44%
Veeva Systems
Aug 28, 2025
Maintains: Neutral
Price Target: $274 → $290
Current: $167.95
Upside: +72.67%
Progyny
Aug 26, 2025
Maintains: Neutral
Price Target: $23 → $25
Current: $18.12
Upside: +37.97%
Doximity
May 27, 2025
Maintains: Neutral
Price Target: $63 → $60
Current: $24.71
Upside: +142.82%
IQVIA Holdings
May 19, 2025
Maintains: Overweight
Price Target: $232 → $177
Current: $176.46
Upside: +0.31%
Omnicell
Mar 20, 2025
Maintains: Neutral
Price Target: $44 → $36
Current: $38.28
Upside: -5.96%
Phreesia
Sep 9, 2024
Maintains: Overweight
Price Target: $27 → $28
Current: $9.17
Upside: +205.34%
Consensus Cloud Solutions
Sep 9, 2024
Downgrades: Underweight
Price Target: $19 → $21
Current: $27.57
Upside: -23.83%
Health Catalyst
Sep 4, 2024
Maintains: Overweight
Price Target: $10 → $13
Current: $1.32
Upside: +884.85%
Aug 19, 2024
Maintains: Overweight
Price Target: $24 → $27
Current: $25.80
Upside: +4.65%
Jul 31, 2024
Downgrades: Underweight
Price Target: $7 → $5
Current: $1.03
Upside: +385.44%